|
| | Preview | Author(s) | Title | Type | Issue Date |
| 101 | | Kastenhofer, Jens | A Novel E. Coli Strain Shows Controllable Cell Leakiness | Präsentation Presentation | 2019 |
| 102 | | Spadiut, Oliver | The Time Has Come - More Control in Inclusion Body Processing | Konferenzbeitrag Inproceedings | 2019 |
| 103 | | Spadiut, Oliver | A tricky endeavour: production of membrane-bound P450s | Präsentation Presentation | 2019 |
| 104 | | Hausjell, Johanna ; Weissensteiner, Julia ; Halbwirth, Heidrun ; Spadiut, Oliver | Challenges in the Recombinant Production of Eukaryotic Cytochrome P450s in microbial cell factories | Vortrag Presentation | Jul-2018 |
| 105 | | Kastenhofer, Jens ; Wurm, David J. ; Mairhofer, Gerald ; Striedner, Gerald ; Spadiut, Oliver | A growth decoupled E. coli expression system allows high-yield recombinant production of antibody fragments | Präsentation Presentation | 2018 |
| 106 | | Pekarsky, Alexander ; Eggenreich, Britta ; Wurm, David J. ; Spadiut, Oliver | A success story - lnclusion bodies are more than molecular waste | Präsentation Presentation | 2018 |
| 107 | | Slouka, Christoph ; Wurm, David J. ; Kroll, Paul ; Herwig, Christoph | Kontinuierliche Upstream-Bioprozessführung mittels Modellen und regelbaren Promotoren | Präsentation Presentation | 2018 |
| 108 | | Spadiut, Oliver | Chormatogram fingerprinting to follow integrated bioprocesses | Präsentation Presentation | 2018 |
| 109 | | Spadiut, Oliver | Inclusion bodies - more than just waste! | Präsentation Presentation | 2018 |
| 110 | | Spadiut, Oliver | Continuous Bioprocessing - how can it be done? | Präsentation Presentation | 2018 |
| 111 | | Slouka, Christoph ; Spadiut, Oliver ; Wurm, David J. ; Kopp, Julian | Enabling continuous upstream bioprocessing using tunable promoters and model predictive control | Präsentation Presentation | 2018 |
| 112 | | Kopp, Julian ; Slouka, Christoph ; Ulonska, Sophia ; Kager, Julian ; Fricke, Jens ; Spadiut, Oliver ; Herwig, Christoph | Impact of glycerol as carbon source onto specific sugar and inducer uptake rates and inclusion body productivity in E. coli BL21(DE3) | Konferenzbeitrag Inproceedings | 2018 |
| 113 | | Kopp, Julian ; Slouka, Christoph ; Ulonska, Sophia ; Kager, Julian ; Fricke, Jens ; Spadiut, Oliver ; Herwig, Christoph | Impact of glycerol as carbon source onto specific sugar and inducer uptake rates and inclusion body productivity in E. coli BL21 (DE3) | Konferenzbeitrag Inproceedings | 2018 |
| 114 | | Wurm, David J. ; Eggenreich, Britta ; Herwig, Christoph ; Berghammer, Gerald ; Spadiut, Oliver | The time has come: lntroducing QbD into inclusion body refolding processes | Konferenzbeitrag Inproceedings | 2018 |
| 115 | | Pekarsky, Alexander ; Eggenreich, Britta ; Wurm, David J. ; Spadiut, Oliver | A success story - lnclusion bodies are more than molecular waste | Konferenzbeitrag Inproceedings | 2018 |
| 116 | | Spadiut, Oliver | Antibody Fragments on a Novel Tandem Fab against Celiac Disease - From Inclusion Body to Product Formulation | Konferenzbeitrag Inproceedings | 2018 |
| 117 | | Hausjell, Johanna ; Wurm, David J. ; Weissensteiner, Julia ; Halbwirth, Heidrun ; Spadiut, Oliver | Using the sustainable waste product Lactose as versatile substance in E. coli bioprocesses | Konferenzbeitrag Inproceedings | 2018 |
| 118 | | Kastenhofer, Jens ; Wurm, David J. ; Mairhofer, Gerald ; Striedner, Gerald ; Spadiut, Oliver | A growth decoupled E. coli expression system allows high-yield recombinant production of antibody fragments | Konferenzbeitrag Inproceedings | 2018 |
| 119 | | Spadiut, Oliver ; Forster, Florian | Medizinprodukte aus dem Bioreaktor | Konferenzbeitrag Inproceedings | 2018 |
| 120 | | Wasinger, Christine ; Hofer, Alexandra ; Spadiut, Oliver ; Hohenegger, Martin | Amino Acid Signature in Human Melanoma Cell Lines from Different Disease Stages | Artikel Article  | 2018 |
